IviGene Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

IviGene General Information

Description

Owner and operator of a biotechnology company intended to facilitate genetic research for the study of antigens. The company's services focus on incorporating an In Vivo Induced Antigen Technology which uses antibodies present in the blood of patients infected with or recently recovered from infection with a particular pathogen and help generate and screen antibodies that serve as probes to screen a genomic expression library of the pathogen in order to identify proteins that are specifically expressed during an actual human infection, enabling medical researchers to develop and innovate drugs using antibodies for treating and curing chronic diseases and for vaccine diagnostic and pharmaceutical development.

Contact Information

Website
www.ivigene.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 12085 Research Drive
  • Alachua, FL 32615
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 12085 Research Drive
  • Alachua, FL 32615
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IviGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Nov-2006 Completed Startup
2. Corporate 12-Mar-2001 Completed Startup
1. Accelerator/Incubator Completed Startup
To view IviGene’s complete valuation and funding history, request access »

IviGene Patents

IviGene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100072196-A1 Controlled venting food package Inactive 24-Sep-2008
WO-2004094644-A2 Vibrio cholerae proteins expressed during infection Inactive 17-Apr-2003
WO-2004094644-A3 Vibrio cholerae proteins expressed during infection Inactive 17-Apr-2003
AU-2003225678-A1 Identification of microbial polynucleotides expressed during infection of a host Inactive 06-Mar-2002
WO-2003076662-A1 Identification of microbial polynucleotides expressed during infection of a host Inactive 06-Mar-2002 C12N15/1072
To view IviGene’s complete patent history, request access »

IviGene Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
UF Innovate Ventures Accelerator/Incubator Minority
Xtl Biopharmaceuticals Corporation Minority
To view IviGene’s complete investors history, request access »

IviGene FAQs

  • When was IviGene founded?

    IviGene was founded in 2000.

  • Where is IviGene headquartered?

    IviGene is headquartered in Alachua, FL.

  • What industry is IviGene in?

    IviGene’s primary industry is Drug Discovery.

  • Is IviGene a private or public company?

    IviGene is a Private company.

  • What is IviGene’s current revenue?

    The current revenue for IviGene is .

  • How much funding has IviGene raised over time?

    IviGene has raised $1M.

  • Who are IviGene’s investors?

    UF Innovate Ventures and Xtl Biopharmaceuticals have invested in IviGene.

  • When was IviGene acquired?

    IviGene was acquired on 20-Nov-2006.

  • Who acquired IviGene?

    IviGene was acquired by Oragenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process